1276
It is concluded that chloral hydrate and methaqualone may be administered safely without additional caution in prothrombin test monitoring during oral anticoagulant therapy.
 ( adverse event: caution ,  chloral hydrate and methaqualone: Treatment, during oral anticoagulant therapy: Treatment, chloral hydrate: Treatment.Drug, methaqualone: Treatment.Drug, anticoagulant: Treatment.Drug, oral: Treatment.Route, chloral hydrate: Combination.Drug, methaqualone: Combination.Drug, anticoagulant: Combination.Drug) 
Locate the role in the text that participated in the event based on the event type and return it in the event list. 
 Option: Event type: adverse event,potential therapeutic event, Arguments type: Treatment.Disorder,Treatment.Time_elapsed,Treatment.Dosage,Subject.Race,Treatment.Drug,Treatment.Route,Subject.Disorder,Treatment.Freq,Treatment,Effect,Subject.Population,Treatment.Duration,Combination.Drug,Subject,Subject.Age,Subject.Gender. 
Text: {0} 
Answer:
 ( adverse event: caution ,  chloral hydrate and methaqualone: Treatment, during oral anticoagulant therapy: Treatment, chloral hydrate: Treatment.Drug, methaqualone: Treatment.Drug, anticoagulant: Treatment.Drug, oral: Treatment.Route, chloral hydrate: Combination.Drug, methaqualone: Combination.Drug, anticoagulant: Combination.Drug) 